RAPT Therapeutics (Nasdaq:RAPT) to Present at J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif. — January 7, 2026 — Leads & Copy — RAPT Therapeutics, Inc. (Nasdaq: RAPT) announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 2:15 p.m. Pacific Time.

The clinical-stage immunology-based biopharmaceutical company focuses on discovering, developing, and commercializing novel therapies for patients living with inflammatory and immunological diseases.

To access the live webcast or subsequent archived recording of the presentation, visit the RAPT Therapeutics website.

Sylvia Wheeler can be reached at swheeler@wheelhouselsa.com.

Aljanae Reynolds can be reached at areynolds@wheelhouselsa.com.

Source: RAPT Therapeutics, Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.